武田製藥 TAK 深 滬
已收盤 05-22 16:00:00 美东时间
16.25
-0.230
-1.40%
華盛通- 最 高16.25
- 今 開16.13
- 成交量 401.14万股
- 最 低 16.07
- 昨 收 16.48
- 總市值 5134.47万
- 52周最高 18.895
- 市盈率 靜 40.93
- 換手率 0.13%
- 52周最低 12.6916
- 委 比 -95.17%
- 總股本 0.03亿
- 歷史最高 18.895
- 量 比 1.39
- 振 幅 1.09%
- 歷史最低 8.492
- 每 手 1
- 風險率 1.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Jury Hits Takeda With $885 Million Antitrust Verdict
Takeda faces nearly $885 million jury verdict in AMITIZA antitrust case and plans post-trial motions and appeal.
05-20 01:48
武田制药反垄断诉讼惨败！被判单倍赔偿 8.85 亿美元，三倍后超 24 亿美元
（来源：抗体圈） 北京时间5月19日凌晨，日本制药巨头武田制药（TSE:4502/NYSE:TAK）发布紧急公告，正式披露其在美国遭遇重大反垄断诉讼一审败诉...
05-19 17:10
Takeda found guilty in 'pay-for-delay' scheme over Amitiza
A federal jury in Boston on Monday found that Takeda Pharmaceutical (TAK) is guilty of conspiring to delay a generic version of its constipation drug Amitza (lubiprostone). The jurors found that Taked...
05-19 04:57
Takeda to shed 4,500 jobs as part of cost-cutting drive
Takeda Pharmaceutical (TAK) has announced that it will eliminate nearly 4,500 roles globally in fiscal 2026 as part of a restructuring drive expected to generate as much as ¥200B ($1.3B) in annualized...
05-14 22:37
武田制药大裁员4500人！新CEO接棒，押注三款First-in-class新药开启增长新时代
（来源：抗体圈） 5月13日，日本制药巨头武田制药（TSE:4502/NYSE:TAK）同步发布 2025 财年（截至 2026 年 3 月 31 日）全年...
05-14 11:45
Takeda's Next Wave Of Drugs Has Investors Watching Closely
Takeda eyes growth with FDA Priority Reviews for narcolepsy and PV drugs. Get the latest on TAK's late-stage pipeline and 2026 forecasts.
05-13 23:38
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
Takeda Pharmaceutical Co Sees FY2026 GAAP EPS $0.66.
Takeda Pharmaceutical Co (NYSE:TAK) is looking for FY2026 GAAP EPS of $0.66.
05-13 19:00
Takeda Pharmaceutical Q4 Adj. EPS $0.28 Beats $0.21 Estimate, Sales $6.978B Miss $7.050B Estimate
Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.21 by 33.33 percent. This is a 75 percent increase over earnings of $0.16 per share from the
05-13 16:47
